Lynx1 Capital Management LP
CIK 0001910456
10% Owner
Filings
16
Latest Apr 2, 2026
Issuers covered
5
Showing
16 of 16
Page 1
Track record
31 of 31 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 31 | 65% | +8.7% | +6.8% | +33.9% | -31.7% |
| 90 days | 30 | 63% | +16.1% | +24.4% | +57.5% | -53.7% |
| 180 days | 27 | 56% | +13.4% | +9.9% | +131.3% | -125.2% |
| 365 days | 12 | 0% | -95.8% | -53.2% | -15.7% | -260.4% |
Issuers
Companies where Lynx1 Capital Management LP has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TCRX | Tscan Therapeutics, Inc. | 7 | Dec 23, 2025 |
| PASG | Passage Bio, Inc. | 4 | Sep 15, 2025 |
| CGEM | Cullinan Oncology, Inc. | 3 | Oct 30, 2025 |
| KRRO | Korro Bio, Inc. | 1 | Apr 2, 2026 |
| NEUP | Neuphoria Therapeutics Inc. | 1 | Oct 23, 2025 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|